
You must be at least 21 years old to access this website.
Our Products are for research and/or investigative purposes and are not suitable for direct human consumption or consumers, nor are they intended for clinical or therapeutic use. The statements and products listed on this website are not intended to diagnose, treat, cure, or prevent any disease. As such, they have not been evaluated or approved by the Federal Food and Drug Administration (the “FDA”). We are not a compounding pharmacy or outsourcing facility as defined under either Section 503A and 503B of the Federal Food, Drug, and Cosmetic Act.
Your cart is empty
Add compounds to get started
Research Comparison
BPC-157 and TB-500 are the two most-studied recovery research peptides, with complementary mechanisms. BPC-157 is a gastric-derived pentadecapeptide studied for angiogenesis and cytoprotection, while TB-500 is a Thymosin Beta-4 fragment studied for actin regulation and cell migration. They are frequently combined.
| Attribute | BPC-157 | TB-500 |
|---|---|---|
| Origin | Gastric juice protein fragment | Thymosin Beta-4 fragment |
| Mechanism focus | Angiogenesis, cytoprotection | Actin upregulation, cell migration |
| Research area | Tendon, GI, neural | Soft tissue, cardiac, wound |
| Availability | Sold individually | Available in the GLOW blend |
They are frequently studied together because their mechanisms are complementary. Our GLOW research blend combines BPC-157 and TB-500 with GHK-Cu in a single vial.